Kamran Shojania

Clinical Trialist, Rheumatology, MD, FRCPC


  • Clinical Professor University of British Columbia, Division of Rheumatology
  • Head, Vancouver General Hospital, Division of Rheumatology
  • Medical Director, Mary Pack Arthritis Program


Research Interests

  • Efficacy of medications on the treatment of rheumatoid arthritis, psoriatic arthritis, gout and vasculitis

  • Health services research


Dr. Kam Shojania is a leader in the field of rheumatology. His research specialty is the efficacy of medications on the treatment of rheumatoid arthritis, psoriatic arthritis, gout and vasculitis.

Learn more


Dr. Kam Shojania is a Clinical Professor and the Head of the Division of Rheumatology, Faculty of Medicine at University of British Columbia (UBC). Dr. Shojania is also Chief of Rheumatology at St. Paul’s Hospital and Vancouver General Hospital. Since 2016, Dr. Shojania is the Medical Director of the Mary Pack Arthritis Program – BC’s Provincial Arthritis Program.

Dr. Shojania is a graduate from UBC medical school where he also completed his specialty training in Internal Medicine and his fellowship in Rheumatology. He was appointed to the UBC Department of Medicine in 1995 and was the UBC Postgraduate Program Director in Rheumatology from 2008 to 2017.

The Arthritis Society awarded Dr. Shojania a Clinician Teacher Award in 2001 to improve the teaching curriculum in rheumatology and attract new recruits to the field.  In addition to his teaching, administrative and research work, Dr. Shojania has a limited private practice at St. Paul’s Hospital and was the director of Clinical Trials with Arthritis Research Canada from 2000 to 2006. He is Head of Rheumatology at both St. Paul’s Hospital and Vancouver General Hospital.

Dr. Shojania’s awards include a Clinician-Teacher Award from The Arthritis Society and a UBC Faculty of Medicine Award for Excellence in Teaching. He is a recipient of the UBC Master Teacher Award, the Howard Stein Award, the Fay Dirks Prize for Excellence in Teaching and the Canadian Rheumatology Association Teacher-Educator Award. He has been an invited speaker at over 60 national and international meetings. Dr. Shojania has over 100 publications and six book chapters.


  1. Katchamart W Bourré-Tessier J; Donka T; Drouin J; Rohekar G; Bykerk VP; Haraoui B; Leclerq S; Mosher D; Pope JE; Shojania K; Thomson J; Thorne JC; Bombardier C. Canadian recommendations for use of methotrexate in patients with rheumatoid arthritis. J Rheumatol 2010;37(7):1422-30
  2. Shojania K, Ratzlaff M. Group visits for rheumatoid arthritis. A pilot study. Clin Rheumatol. 2009;29(6):625
  3. Hemmati I, Ensworth S, Shojania K. Coarctation of the Aorta in an Infant Exposed to Etanercept in Utero. J Rheumatol 2009;36(12):2848
  4. Choi HK. Al-Arfaj AM. Eftekhari A. Munk PL. Shojania K. Reid G. Nicolaou S. Dual energy computed tomography in tophaceous gout. Ann Rheum Dis 2009;68(10):1609-12
  5. Maksymowych, WP, Rahman, P, Shojania, K, Olszynski, WP, Thomson, GTD, Ballal, S, Wong, RL, Inman, RD. Beneficial effects of adalimumab on biomarkers reflecting structural damage in patients with ankylosing spondylitis. J Rheumatol 2008;35:2030;7.
  6. Cibere J, Thorne A, Bellamy N, Greidanus N, Chalmers A, Mahomed N, Shojania K, Kopec J, Esdaile JM. Reliability of the hip examination in osteoarthritis: Effect of standardization. Arthritis Rheum 2008;59:373-81.
  7. Reynolds J, Shojania K, Marra CA. Abatacept: A novel treatment for moderate to severe rheumatoid arthritis. Pharmacotherapy 2007;27(12):1693-701.
  8. Maksymowych, WP, Gladman D, Rahman P, Boonen A, Bykerk V, Choquette D, Dimond S, Fortin P, Karsh J, Klinkhoff AV, Mosher D, Mulholland K, Olszynski WP, Russell AS, Savage L, Shanner L, Shojania K, Starr M, Thomson G, Zummer M, Inman R. The Canadian Rheumatology Association/Spondylitis Research Consortium of Canada treatment recommendations for the management of Spondyloarthritis: A national multidisciplinary stakeholder project. J Rheumatol 2007;34:2273-84.
  9. Kherani RB, Shojania K. Septic arthritis in patients with pre-existing inflammatory arthritis. CMAJ 176:1605-8.
  10. de Gannes GC, Ghoreishi M, Pope J, Russell A, Bell D, Adams S, Shojania K, Martinka M, Dutz JP. Psoriasis and pustular dermatitis triggered by TNF alpha inhibitors in patients with rheumatologic conditions. Arch Dermatol 2007;143:223-31.
  11. Iverson GL, Le Page J, Koehler BK, Shojania